Results 181 to 190 of about 50,392 (230)

Loss of HTLV-1-specific CD8<sup>+</sup> T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma. [PDF]

open access: yesBlood Neoplasia
Weterings DA   +7 more
europepmc   +1 more source

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL. [PDF]

open access: yesTumour Virus Res
Ladet J   +9 more
europepmc   +1 more source

HTLV-1-Infected CD4<sup>+</sup> T Cells Drive Spontaneous Lymphoproliferation and Virus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocyte Expansion in HAM/TSP. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Dozono M   +8 more
europepmc   +1 more source

Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial. [PDF]

open access: yesClin Infect Dis
Brites C   +8 more
europepmc   +1 more source

HTLV-I infection among Japanese imigrants living in a rural area in the north of Brazil.

open access: yes, 2002
Pontes, Gemilson Soares   +10 more
core  
Some of the next articles are maybe not open access.

Related searches:

HTLV-I and HTLV-II

2003
Human T-cell lymphotropic virus type I (HTLV-I) is known as the causative agent for adult T-cell leukemia (ATL). This same virus was found to be related to another human disease, a progressive spastic paraparesis, found independently in two areas of the world, the Caribbean basin and Japan.
openaire   +2 more sources

HTLV in Sweden

Aids Reviews
Sweden is a country with a low prevalence of human lymphotropic T-cell virus (HTLV) infection, estimated at < 0.005%, but the infection rate is notably higher in specific risk groups such as HTLV-2 among intravenous drug users (IVDU) and people originating from HTLV-1 highly endemic areas.
Jan, Vesterbacka   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy